Background Colon cancer management continues to evolve with signifi cant advances in chemotherapy, surgical technique and palliative interventions. As the options of therapy have improved, so have the challenges of management of primary colon cancer. Review A review of historical and up to date literature was undertaken utilising Medline/PubMed to examine relevant topics of interest-related to the surgical management. Enhanced knowledge of genetics associated with colon cancer has improved our care of patients with hereditary colon cancer syndromes. Additionally, traditional approaches to surgical intervention for primary colon cancer have been questioned and will be discussed in this review including the role of laparoscopy, use of mechanical bowel preparation, management of the primary tumour in the face of metastatic disease, as well as the role of palliative intervention in select patients. Conclusion Colon cancer has seen improvement and expansion of therapeutic approaches to primary colon cancer. Laparoscopy and palliative interventions have become widely accepted with level I evidence to demonstrate good patient outcomes. Traditional dogma with mechanical bowel preparation has been challenged and debunked with REVIEW ARTICLE regards to the effi cacious benefi ts previously accepted. The management of the primary tumour has now become increasingly complex as it appears to be a reasonable approach to manage the primary tumour non-operatively in select cases of extracolonic disease requiring management.
Introduction
Colorectal cancer (CRC) comprises 10% of the over 500,000 annual cancer deaths in the United States, making it the third most common cancer in men and women. In 2009, it is projected that 146,970 new cases of CRC will be diagnosed with 49,920 dying of disease [1] . Over the last 7 years, CRC death rates in men and women have decreased steadily (17% and 24%, respectively). These advances may be attributed to a better understanding of the disease genetics, improved surveillance, technical advances in the operations, increasing indications for the use neoadjuvant and adjuvant chemotherapy, and better palliation.
As operative and non-operative therapies have evolved and improved, the management of CRC has become multidisciplinary and more complex, particularly in the face of advanced disease. The role of surgical intervention, or at least the timing of it, is changing. Herein, we will review many of the evolving issues regarding surgery for CRC. Specifi cally, we will discuss the current recommendations related to role of colectomy in hereditary CRC syndromes, bowel preparations, laparoscopic surgery, management of the primary lesion in the face of metastatic disease, role of endoscopic interventions for palliation and treatment of obstructive symptomatology, and briefl y discuss adjuvant and neoadjuvant therapies.
Hereditary colorectal cancer syndromes
The two major syndromes which make up approximately half of the familial cases of CRC are familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC). FAP is an autosomal dominant disease caused by mutations in the adenomatous polyposis coli (APC) gene. Polyps can be found anywhere throughout the gastrointestinal tract and the disease is characterised by the presence of hundreds of adenomatous polyps, 100% penetrance, and a 100% risk of developing colon cancer by age 40 [2, 3] . Screening for at risk family members should begin at puberty and consists of genetic testing to confi rm risk and/or biennial fl exible sigmoidoscopy [4] . The timing of surgery is often dependent upon the degree of polyposis [5] . Patients with mild polyposis may have their surgery delayed until their mid to late teens given the lower risk of earlier cancer development. However, patients with heavy polyp burden run a greater risk of the development of cancer and may need their surgery sooner [5, 6] . Surgical management options for these patients include total proctocolectomy with ileostomy (TPC), total abdominal colectomy with ileorectal anastamosis (IRA), and total proctocolectomy with ileal pouch anal anastamosis (IPAA). TPC is reserved for those patients who have poor sphincter function or patients who are not able to tolerate multiple bowel movements daily. IRA is occasionally offered to those patients who have less rectal disease, but it still carries an increased chance of developing a rectal cancer [7] . IPAA is considered the gold standard by removing all colorectal tissue at risk while maintaining sphincter function and bowel continuity. Lifelong surveillance for recurrence with fl exible endoscopy is still required in patients undergoing IRA and IPAA [6] .
HNPCC or Lynch syndrome, is an autosomal dominant disorder with high penetrance in mutation carriers caused by germline mutations in one of several DNA mismatch repair (MMR) genes. These are characterised by an early onset of CRCs, a predominance of developing right-sided colon cancers, metachronous lesions, and both benign and malignant extracolonic tumours [4] . Determining whether a patient has HNPCC is based on a thorough history utilising the Amsterdam criteria requirement that there be three relatives (one must be a fi rst degree relative of the other two) with an HNPCC-related cancer, that two or more successive generations be involved, and that at least one relative have a CRC diagnosed before the age of 50 [8, 9] . CRC can occur in 80% of patients with MMR mutation and endometrial, gastric, urinary tract and ovarian cancers are also seen in this group [10] . Screening takes into account the possibility of both colonic and extracolonic malignancies with surveillance colonoscopy every 1-2 years beginning at the age of 20-25 or 10 years prior to the age of CRC onset in a fi rst degree relative, then annually after the age of 40. Females at 25-35 years of age should undergo annual transvaginal ultrasonography, endometrial aspirations, and have CA-125 levels checked. Oesophagogasrtoduodenoscopy can be utilised in patients to screen for gastric cancer and ultrasound and urine cytology can be utilised to screen for urinary tract malignancy [11] . Surgical management for patients with HNPCC, when elected, includes either a prophylactic total abdominal colectomy with IRA or a segmental colectomy with yearly colonoscopy [12] . Lifelong surveillance with fl exible endoscopy is still required in both groups of patients because of the high chance of metachronous cancer.
Preoperative bowel preparation
The use of mechanical bowel preparation (MBP) in combination with oral antibiotics described by Nichols in 1973 was the fi rst major stride in reducing wound infection and outcomes following colorectal surgery [13] . Since the subsequent introduction and routine use of perioperative intravenous antibiotics, however, the role of mechanical bowel preparation has been challenged. In fact, this specifi c issue has been addressed through more randomised controlled trials (RCTs) than virtually any other subject in colorectal surgery. Over the decades that followed Nichols' initial reports, mechanical bowel preparation continued to be widely used without any supporting data with regards to pelvic abscesses, wound infections, abdominal sepsis, reoperations or death. In a meta-analysis by Slim et al. in 2004, multiple RCTs were examined [14] . No benefi t to MBP was seen and, in addition, several trials demonstrated increased morbidity with the use of MBP. In an updated 2009 metaanalysis, Slim et al. examined 14 RCTs with a total of 4,859 patients undergoing colonic resection exclusively without inclusion of rectal cancer patients [15] . These patients were divided into two groups; 2,452 who had MBP and 2,407 who did not. The primary endpoint was leak rate assessment. Secondary endpoints examined complications inclusive of abscesses, wound infections, sepsis, reoperations and death. Results demonstrated no statistically signifi cant difference with respect to leak rates (p = 0.46), abdominal abscesses (p = 0.75), wound infections (p = 0.11), extra-abdominal sepsis (p = 0.12), reoperations (p = 0.63) or death (p = 0.70) [15] . The American Society of Colorectal Surgeons (ASCRS) support this by stating, "All types of mechanical preparation occasionally engender serious complications [16] [17] [18] . The balance remains tipped in favour of bowel preparation by the weight of tradition and by the procedure's intuitive appeal to surgeons and patients alike." The only use of routine MBP supported by the ASCRS website guidelines are in cases requiring intraoperative endoscopy.
